Literature DB >> 6655483

Cognitive and personality function in myotonic muscular dystrophy.

T D Bird, C Follett, E Griep.   

Abstract

Twenty-nine patients with myotonic dystrophy from 14 families were tested with the Wechsler and Shipley measures of cognitive function. Forty-one per cent of the subjects had little or no physical handicap. Approximately one-third had low Wechsler scores, whereas 7% had relatively high scores. There was a trend for affected females to have poorer cognitive function than males. Limited cognitive ability correlated with maternal inheritance of the gene and severe physical handicap, but there were individual exceptions. Strongest cognitive abilities were verbal and informational, whereas the weakest were immediate recall, abstraction and spatial manipulation and orientation. There was no evidence of intellectual decline with time. Signs of cerebral atrophy on CT scans were uncommon, occurring for certain in only one of 19 subjects. Personality profiles were also constructed for 25 myotonic subjects using interview and MMPI techniques. Forty-four per cent of the subjects had unremarkable personality profiles, 24% had mild personality difficulties and 32% had prominent personality abnormalities. Serious personality difficulty was most common in patients with low cognitive ability and advanced physical handicap. There was no "typical" personality pattern representative of the entire group. It is likely that many personality problems were the result of individuals with limited resources attempting to cope with their physically deforming and debilitating neuromuscular disorder.

Entities:  

Mesh:

Year:  1983        PMID: 6655483      PMCID: PMC491732          DOI: 10.1136/jnnp.46.11.971

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Mental deficiency associated with muscular dystrophy. A neuropathological study.

Authors:  N P Rosman; B A Kakulas
Journal:  Brain       Date:  1966-12       Impact factor: 13.501

2.  Relationships among education, the MMPI, and WAIS measures of psychopathology.

Authors:  P B Lacks; K Keefe
Journal:  J Clin Psychol       Date:  1970-10

3.  Cytoplasmic inclusion bodies within neurons of the thalamus in myotonic dystrophy. A light and electron microscope study.

Authors:  A Culebras; R G Feldman; F B Merk
Journal:  J Neurol Sci       Date:  1973-07       Impact factor: 3.181

4.  Dystrophia myotonica. Repeated pneumoencephalographic studies in ten patients.

Authors:  S Refsum; A Lonnum; O Sjaastad; A Engeset
Journal:  Neurology       Date:  1967-04       Impact factor: 9.910

5.  Involvement of the nervous system in muscular dystrophies in man.

Authors:  V Dubowitz
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

6.  Early onset myotonic dystrophy. Clinical and laboratory findings in five families and a review of the literature.

Authors:  G V Watters; T W Williams
Journal:  Arch Neurol       Date:  1967-08

7.  Alveolar hypoventilation and hyperosmnia in myotonic dystrophy.

Authors:  G Coccagna; M Mantovani; C Parchi; F Mironi; E Lugaresi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-10       Impact factor: 10.154

8.  Myotonic dystrophy: a neglected cause of mental retardation.

Authors:  R Calderon
Journal:  J Pediatr       Date:  1966-03       Impact factor: 4.406

9.  Psychodynamics in a chronic debilitating hereditary disease. Myotonia dystrophica.

Authors:  H T Lynch; R L Tips; A Krush
Journal:  Arch Gen Psychiatry       Date:  1966-02

10.  Ultrastructure of thalamic neuronal inclusions in myotonic dystrophy.

Authors:  H M Wiśniewski; K Berry; A J Spiro
Journal:  J Neurol Sci       Date:  1975-03       Impact factor: 3.181

View more
  20 in total

1.  Mild myotonic dystrophy is associated with memory impairment in the context of normal general intelligence.

Authors:  J S Rubinsztein; D C Rubinsztein; P J McKenna; S Goodburn; A J Holland
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

2.  Pulmonary function and resting breathing pattern in myotonic dystrophy.

Authors:  J M Bogaard; F G van der Meché; I Hendriks; C Ververs
Journal:  Lung       Date:  1992       Impact factor: 2.584

3.  Neuropsychological deficits in myotonic muscular dystrophy.

Authors:  P Malloy; S K Mishra; S H Adler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

Review 4.  Therapeutics development in myotonic dystrophy type 1.

Authors:  Erin Pennock Foff; Mani S Mahadevan
Journal:  Muscle Nerve       Date:  2011-05-23       Impact factor: 3.217

5.  Apathy and hypersomnia are common features of myotonic dystrophy.

Authors:  J S Rubinsztein; D C Rubinsztein; S Goodburn; A J Holland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

6.  Neuropsychological profile in myotonic dystrophy.

Authors:  B Censori; M Danni; M Del Pesce; L Provinciali
Journal:  J Neurol       Date:  1990-07       Impact factor: 4.849

7.  Cognitive and personality function in myotonic muscular dystrophy.

Authors:  R A Brumback; H Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

8.  Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.

Authors:  Guangbin Xia; Yuanzheng Gao; Shouguang Jin; S H Subramony; Naohiro Terada; Laura P W Ranum; Maurice S Swanson; Tetsuo Ashizawa
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

9.  Psychopathological and emotional deficits in myotonic dystrophy.

Authors:  C Bungener; R Jouvent; C Delaporte
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

10.  Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.

Authors:  Guangbin Xia; Katherine E Santostefano; Marianne Goodwin; Jilin Liu; S H Subramony; Maurice S Swanson; Naohiro Terada; Tetsuo Ashizawa
Journal:  Cell Reprogram       Date:  2013-04       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.